Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology
Year: 2018
Type: review
Abstract: The Precision Neurology development process implements systems theory with system biology and neurophysiology in a parallel, bidirectional research path: a combined hypothesis-driven investigation of systems dysfunction within distinct molecular, cellular, and large-scale neural network systems in both animal models as well as through tests for the usefulness of these candidate dynamic systems biomarkers in different diseases and subgroups at different stages of pathophysiological progression. This translational research path is paralleled by an "omics"-based, hypothesis-free, exploratory research pathway, which will collect multimodal data from progressing asymptomatic, preclinical, and clinical neurodegenerative disease (ND) populations, within the wide continuous biological and clinical spectrum of ND, applying high-throughput and high-content technologies combined with powerful computational and statistical modeling tools, aimed at identifying novel dysfunctional systems and predictive marker signatures associated with ND. The goals are to identify common biological denominators or differentiating classifiers across the continuum of ND during detectable stages of pathophysiological progression, characterize systems-based intermediate endophenotypes, validate multi-modal novel diagnostic systems biomarkers, and advance clinical intervention trial designs by utilizing systems-based intermediate endophenotypes and candidate surrogate markers. Achieving these goals is key to the ultimate development of early and effective individualized treatment of ND, such as Alzheimer's disease. The Alzheimer Precision Medicine Initiative (APMI) and cohort program (APMI-CP), as well as the Paris based core of the Sorbonne University Clinical Research Group "Alzheimer Precision Medicine" (GRC-APM) were recently launched to facilitate the passageway from conventional clinical diagnostic and drug development toward breakthrough innovation based on the investigation of the comprehensive biological nature of aging individuals. The APMI movement is gaining momentum to systematically apply both systems neurophysiology and systems biology in exploratory translational neuroscience research on ND.
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-179932
Authors: Harald Hampel, for the Alzheimer Precision Medicine Initiative (APMI), Nicola Toschi, Claudio Babiloni, Filippo Baldacci, Keith L. Black, Arun L.W. Bokde, René S. Bun, Francesco Cacciola, Enrica Cavedo, Patrizia A. Chiesa, Olivier Colliot, Cristina-Maria Coman, Bruno Dubois, Andrea Duggento, Stanley Durrleman, Maria-Teresa Ferretti, Nathalie George, Remy Genthon, Marie-Odile Habert, Karl Herholz, Yosef Koronyo, Maya Koronyo-Hamaoui, Foudil Lamari, Todd Langevin, Stéphane Lehéricy, Jean Lorenceau, Christian Neri, Robert Nisticò, Francis Nyasse-Messene, Craig Ritchie, Simone Rossi, Emiliano Santarnecchi, Olaf Sporns, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Erfan Younesi, Francesco Garaci, Simone Lista
Institutions: Centre National de la Recherche Scientifique, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, AXA Research Fund, Institut du Cerveau, Alzheimer Precision Medicine, University of Rome Tor Vergata, Harvard University, Athinoula A. Martinos Center for Biomedical Imaging, Istituti di Ricovero e Cura a Carattere Scientifico, IRCCS San Raffaele Roma, Sapienza University of Rome, University of Pisa, Cedars-Sinai Medical Center, Trinity College Dublin, Azienda Ospedaliera Universitaria Senese, Centro San Giovanni di Dio Fatebenefratelli, Institut national de recherche en sciences et technologies du numérique, Université Pierre-et-Marie-Curie, University of Zurich, Laboratoire d’Imagerie Biomédicale, University of Manchester, Institut de la Vision, Institut de Biologie Paris-Seine, European Brain Research Institute, University of Edinburgh, University of Siena, Beth Israel Deaconess Medical Center, Berenson Allen Center for Noninvasive Brain Stimulation, Indiana University Bloomington, Indiana University, Università degli studi di Cassino e del Lazio Meridionale
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, precision neurology
Open Access status: hybrid
Funders: National Science Foundation, GlaxoSmithKline, Rotary Foundation, European Commission, Agence Nationale de la Recherche, AXA Research Fund, Assistance Publique - Hôpitaux de Paris, Meath Foundation, Sorbonne Université, Fondation pour la Recherche sur Alzheimer, National Institutes of Health, Horizon 2020 Framework Programme, National Institute on Aging, National Center for Complementary and Integrative Health, H2020 European Research Council
Awards: G120899302, G1258743643, G1936513239, G2017605187, G2871482981, G3103753459, CRCNS: Linking connectomic and large-Scale Dynamics of the Human Brain, A noninvasive optical imaging of retinal amyloid beta deposits in AD patients, Data-driven models for Progression Of Neurological Disease, G434337789, G4937468798, G4950536974, France Life Imaging, Retinal Imaging of Alzheimer's Disease Pathology, Learning spatiotemporal patterns in longitudinal image data sets of the aging brain, Experimental and theoretical investigation of the multi-scale emergence of parametric working memory in prefrontal cortex recurrent networks, Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina
OpenAlex ID: W2789817872
